The novel HLA‐B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual
HLA · 2024
DOI: 10.1111/tan.15351 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Xiao Lou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: HLA-B Antigens, Nucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*51:389 differs from HLA‐B*51:02:01:01 by one nucleotide in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
- Department of Gastrointestinal Oncology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
- Department of Laboratory, Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
ORCID-Profile: Lin An
Zitieren
APA
Lou, X., Zhao, C., An, L., Yu, C., & Guo, M. (2024). The novel HLA‐B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. https://doi.org/10.1111/tan.15351
Vancouver
Lou X, Zhao C, An L, Yu C, Guo M. The novel HLA‐B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. 2024. doi:10.1111/tan.15351
BibTeX
@article{Lou2024,
author = {Lou, Xiao and Zhao, Chuanhua and An, Lin and Yu, Changlin and Guo, Mei},
title = {The novel HLA‐B*51:389 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15351}
}
EUVIMED